Sama Therapeutics

Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The companys agile SaaS platform, iMAGiNETM, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing software as medical device for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We invite partners to join our mission unlocking brain health through integrative neurotechnology and proven transprognostic algorithms: https://brainclinics.com/tdbrain-challenge/...

Precision medicine,neuropsychiatry,psychedelics,and ai/ml

Sama therapeutics operates in the Biotechnology research industry.

Sama therapeutics's revenue is 11m - 100m

Sama therapeutics has 11 - 50 employees.